| Description |
| Product Type |
Product Size |
| Capsules |
5'S |
| Product Company |
| Barrett Pharma |
Cefixime 400mg |
| Product Type |
Product Size |
| Capsules |
5'S |
| Product Company |
| Sami Pharmaceutical |
Cefixime Trihydrate 400mg |
| Product Type |
Product Size |
| Tablet |
100'S |
| Product Company |
| GSK/td>
|
Co Trimoxazole 800/160mg (Sulfamethoxazole+ Trimethoprim) |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Sandoz |
|
| Product Type |
Product Size |
| Tablets
|
12'S |
| Product Company |
| Sami Pharmaceutical |
Linezolid 600mg
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Bosch Pharmaceuticals |
Tazobactum + Piperacillin 4.5g, 2.5g |
| Content | Cefixime is used to treat certain infections caused by bacteria such as bronchitis (infection of the airway tubes leading to the lungs); gonorrhea (a sexually transmitted disease); and infections of the ears, throat, tonsils, and urinary tract. Cefixime is in a class of medications called cephalosporin antibiotics. | Cefixime, an antibiotic, is a third-generation cephalosporin like ceftriaxone and cefotaxime. Cefixime is highly stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to cefixime. | Co-trimoxazole is a combination of trimethoprim and sulfamethoxazole and is in a class of medications called sulfonamides. It works by stopping the growth of bacteria.
| Oxaliplatin is a platinum based chemotherapy agent used to treat carcinoma of the colon or rectum or stage III colon cancer. | Linezolid is used to treat infections, including pneumonia, and infections of the skin . Linezolid is in a class of antibacterials called oxazolidinones. It works by stopping the growth of bacteria.
| Tazobactum is a beta lactamase inhibitor administered with antibiotics such as piperacilin to prevent their degradation resulting in increased efficacy. |
Reviews
There are no reviews yet.